Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $31.3 million.

  • Merit Medical Systems' Depreciation & Amortization (CF) rose 1860.77% to $31.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.2 million, marking a year-over-year increase of 2305.18%. This contributed to the annual value of $102.7 million for FY2024, which is 1414.01% up from last year.
  • Merit Medical Systems' Depreciation & Amortization (CF) amounted to $31.3 million in Q3 2025, which was up 1860.77% from $31.0 million recorded in Q2 2025.
  • In the past 5 years, Merit Medical Systems' Depreciation & Amortization (CF) ranged from a high of $31.3 million in Q3 2025 and a low of $20.4 million during Q3 2022
  • Its 5-year average for Depreciation & Amortization (CF) is $23.7 million, with a median of $21.8 million in 2023.
  • In the last 5 years, Merit Medical Systems' Depreciation & Amortization (CF) plummeted by 1151.53% in 2021 and then soared by 2876.59% in 2025.
  • Quarter analysis of 5 years shows Merit Medical Systems' Depreciation & Amortization (CF) stood at $20.9 million in 2021, then decreased by 1.92% to $20.5 million in 2022, then grew by 15.29% to $23.6 million in 2023, then rose by 21.12% to $28.6 million in 2024, then rose by 9.44% to $31.3 million in 2025.
  • Its Depreciation & Amortization (CF) was $31.3 million in Q3 2025, compared to $31.0 million in Q2 2025 and $29.3 million in Q1 2025.